High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli

被引:142
作者
Iwata, H
Fujita, K
Kushida, H
Suzuki, A
Konno, Y
Nakamura, K
Fujino, A
Kamataki, T
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Div Drug Metab, Kita Ku, Sapporo, Hokkaido 060, Japan
[2] Mitsubishi Chem Safety Inst Ltd, Dept Drug Metab, Hasaki, Ibaraki 31402, Japan
关键词
human P450; heterologous expression; E-coli; drug metabolism;
D O I
10.1016/S0006-2952(97)00643-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Forms of human cytochrome P450 (P450 or CYP), such as CYP1A1, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4, were expressed or co-expressed together with human NADPH P450 reductase in Escherichia coli. When P450 was expressed alone in E. coli, the expression level of holo-P450 ranged from 310 to 1620 nmol/L of culture. The expression level of holo-P450 decreased by co-expression with the reductase, and the level ranged from 66 to 381 nmol/L of culture. The expression level of the reductase varied depending on the forms of P450 co-expressed, and ranged from 204 to 937 U/L of culture. We assayed the catalytic activity of P450 using E. coli cells disrupted by freeze-thaw. When co expressed with the reductase, human P450 catalyzed the oxidation of representative substrates at efficient rates. The rates appeared comparable to the reported activities of P450 in a reconstituted system containing purified preparations of P450 and the reductase. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1315 / 1325
页数:11
相关论文
共 73 条
  • [1] SIMPLE AND SENSITIVE ASSAY OF 7-ETHOXYCOUMARIN DEETHYLATION
    AITIO, A
    [J]. ANALYTICAL BIOCHEMISTRY, 1978, 85 (02) : 488 - 491
  • [2] Amri H, 1986, XENOBIOTICA, V16, P351
  • [3] 5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1
    AOYAMA, T
    YAMANO, S
    GUZELIAN, PS
    GELBOIN, HV
    GONZALEZ, FJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4790 - 4793
  • [4] CYTOCHROME-B5 POTENTIATION OF CYTOCHROME-P-450 CATALYTIC ACTIVITY DEMONSTRATED BY A VACCINIA VIRUS-MEDIATED INSITU RECONSTITUTION SYSTEM
    AOYAMA, T
    NAGATA, K
    YAMAZOE, Y
    KATO, R
    MATSUNAGA, E
    GELBOIN, HV
    GONZALEZ, FJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (14) : 5425 - 5429
  • [5] ARLOTTO MP, 1991, METHOD ENZYMOL, V206, P454
  • [6] EXPRESSION AND ENZYMATIC-ACTIVITY OF RECOMBINANT CYTOCHROME-P450 17-ALPHA-HYDROXYLASE IN ESCHERICHIA-COLI
    BARNES, HJ
    ARLOTTO, MP
    WATERMAN, MR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) : 5597 - 5601
  • [7] Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli
    Blake, JAR
    Pritchard, M
    Ding, SH
    Smith, GCM
    Burchell, B
    Wolf, CR
    Friedberg, T
    [J]. FEBS LETTERS, 1996, 397 (2-3) : 210 - 214
  • [8] PRODUCTION OF CYTOCHROME P450 REDUCTASE YEAST-RAT HYBRID PROTEINS IN SACCHAROMYCES-CEREVISIAE
    BLIGH, HFJ
    WOLF, CR
    SMITH, G
    BEGGS, JD
    [J]. GENE, 1992, 110 (01) : 33 - 39
  • [9] Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321
  • [10] BURKE MD, 1983, CHEM-BIOL INTERACT, V45, P243